Human Holdings Co., Ltd. (2415.T)
Tokyo, JP
Established in Tokyo, Japan, in 1985, Human Holdings Co., Ltd. is a multifaceted enterprise with operations spanning domestic and international markets, primarily centered around human resources, education, and elder care. Within its human resource division, the company provides a comprehensive suite of services including temporary staffing, talent acquisition, business process outsourcing, online job placement services, robotic process automation (RPA) implementation, and tailored system development. The education segment offers extensive programs, from school lectures and e-learning for various age groups—ranging from infants to vocational students—to study abroad initiatives, nursery school management, corporate training, and linguistic services like translation and interpretation. Its nursing care offerings encompass a broad spectrum of support, such as day services, in-home assistance, residential group homes, small-scale multi-functional care, and full-service fee-based nursing facilities, complemented by care facility management and caregiver training. Beyond these core areas, Human Holdings also manages a nail salon and sells related products, oversees professional sports teams like the Osaka Evessa basketball team and the Human Academy CREST GAMING e-sports team, and delivers IT solutions including system integration, content planning and production, and digital marketing strategies.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.31% | -2.70% | -11.37% | -14.86% | -18.18% | -20.42% | -8.36% | +53.97% | +77.88% | +109.71% | -40.24% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Education & Training Services: +8.8%+2.2% Q1'26: +3.0% (vs Q1'25)
-
EPS growth Education & Training Services: +23.7%-15.0% Q1'26: -30.7% (vs Q1'25)
-
FCF margin FCF growth · Education & Training Services: +33.4%+2.0% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Education & Training Services: +14.0%+3.5% Q1'26: +5.5% (vs Q1'25)
-
ROIC Education & Training Services: +8.8%— Q1'26: -1,549.9% (vs Q1'25)
-
Share dilution Education & Training Services: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Education & Training Services: -0.27×2.05× ★ Q1'26: 1.39× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
74.42B
est: 75.69B (-1.7%)
|
78.76B
est: 80.00B (-1.5%)
|
84.31B
est: 85.80B (-1.7%)
|
85.99B
est: 91.00B (-5.5%)
|
85.81B
est: 96.00B (-10.6%)
|
100.33B
est: 101.00B (-0.7%)
|
103.00B
103.00B – 103.00B
+2.0% YoY
|
104.80B
104.80B – 104.80B
+1.7% YoY
|
107.00B
107.00B – 107.00B
+2.1% YoY
|
| EBITDA |
2.68B
est: 3.20B (-16.4%)
|
2.79B
est: 3.38B (-17.5%)
|
3.08B
est: 3.63B (-15.1%)
|
2.98B
est: 3.85B (-22.6%)
|
3.59B
est: 4.06B (-11.5%)
|
4.31B
est: 4.03B (+7.0%)
|
4.11B
4.11B – 4.11B
+2.0% YoY
|
4.18B
4.18B – 4.18B
+1.7% YoY
|
4.27B
4.27B – 4.27B
+2.1% YoY
|
| EBIT |
1.83B
est: 2.43B (-24.9%)
|
1.89B
est: 2.57B (-26.5%)
|
2.14B
est: 2.75B (-22.3%)
|
2.00B
est: 2.92B (-31.5%)
|
2.63B
est: 3.08B (-14.8%)
|
3.40B
est: 3.00B (+13.1%)
|
3.06B
3.06B – 3.06B
+2.0% YoY
|
3.12B
3.12B – 3.12B
+1.7% YoY
|
3.18B
3.18B – 3.18B
+2.1% YoY
|
| Net Income |
1.00B
est: 1.28B (-21.7%)
|
1.13B
est: 1.25B (-9.5%)
|
1.22B
est: 973.45M (+25.1%)
|
848.44M
est: 1.08B (-21.3%)
|
1.44B
est: 1.18B (+21.7%)
|
2.61B
est: 2.38B (+9.6%)
|
2.50B
2.50B – 2.50B
+5.1% YoY
|
2.50B
2.50B – 2.50B
+0.0% YoY
|
2.55B
2.55B – 2.55B
+2.0% YoY
|
| SGA |
18.29B
est: 16.75B (+9.2%)
|
19.54B
est: 17.70B (+10.4%)
|
20.54B
est: 18.99B (+8.2%)
|
20.92B
est: 20.14B (+3.9%)
|
19.71B
est: 21.25B (-7.2%)
|
21.95B
est: 22.35B (-1.8%)
|
22.79B
22.79B – 22.79B
+2.0% YoY
|
23.19B
23.19B – 23.19B
+1.7% YoY
|
23.68B
23.68B – 23.68B
+2.1% YoY
|
| EPS |
92.15
est: 123.30 (-25.3%)
|
103.98
est: 120.40 (-13.6%)
|
111.95
est: 93.80 (+19.3%)
|
78.00
est: 103.90 (-24.9%)
|
132.36
est: 114.00 (+16.1%)
|
251.21
est: 229.30 (+9.6%)
|
240.90
240.90 – 240.90
+5.1% YoY
|
240.90
240.90 – 240.90
+0.0% YoY
|
245.70
245.70 – 245.70
+2.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-21 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-20 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Militia Long/Short Equity ETF ORR | 0.12% | 168.0K | 14.19% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Koichi Sato | Founder & Director | — | male |
| Shinya Setoguchi | Director of Nursing Business & Director | — | male |
| Tomonari Sato | Chief Executive Officer, President & Representative Director | — | male |
| Yasuhiro Sato | Director of Corporate Planning & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2415.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
